In terms of tumour size control, when MLKL-overexpressing KPC cells were subcutaneously transplanted into C57BL/6 mice, the combination regimen achieved the greatest improvement in tumour size control and survival, surpassing that of GW or CD47 blockade alone (Fig. 9g, h, Supplementary Fig. 12f). Here, CD47 is linked to neoplasm.